Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Stock analysts at Brookline Capital Management dropped their Q3 2025 earnings per share estimates for Bioceres Crop Solutions in a research note issued on Thursday, February 13th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will post earnings per share of ($0.05) for the quarter, down from their previous estimate of $0.02. The consensus estimate for Bioceres Crop Solutions' current full-year earnings is ($0.05) per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions' Q4 2025 earnings at $0.15 EPS, FY2025 earnings at $0.02 EPS, FY2027 earnings at $0.66 EPS, FY2028 earnings at $0.77 EPS and FY2029 earnings at $0.97 EPS.
A number of other research analysts have also commented on the company. Lake Street Capital cut their price target on Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating for the company in a report on Friday, February 7th. Canaccord Genuity Group cut their target price on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating for the company in a research note on Thursday, February 13th. Finally, Oppenheimer decreased their price target on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an "outperform" rating on the stock in a research report on Tuesday, January 28th. Four research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Bioceres Crop Solutions has a consensus rating of "Buy" and a consensus target price of $9.88.
Get Our Latest Analysis on BIOX
Bioceres Crop Solutions Stock Performance
NASDAQ:BIOX traded up $0.03 during mid-day trading on Monday, hitting $4.74. 256,547 shares of the company's stock traded hands, compared to its average volume of 304,786. The firm has a market capitalization of $297.25 million, a price-to-earnings ratio of 237.12 and a beta of 0.57. The firm has a 50 day moving average of $6.35 and a two-hundred day moving average of $7.47. The company has a current ratio of 1.33, a quick ratio of 0.96 and a debt-to-equity ratio of 0.43. Bioceres Crop Solutions has a 12 month low of $4.42 and a 12 month high of $13.60.
Institutional Investors Weigh In On Bioceres Crop Solutions
A number of institutional investors have recently bought and sold shares of the business. Fourth Sail Capital LP boosted its holdings in Bioceres Crop Solutions by 61.6% during the third quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company's stock valued at $24,957,000 after purchasing an additional 1,209,277 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Bioceres Crop Solutions by 135.0% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 752,335 shares of the company's stock worth $4,574,000 after buying an additional 432,206 shares during the period. Long Focus Capital Management LLC boosted its stake in Bioceres Crop Solutions by 130.7% in the 4th quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company's stock valued at $4,528,000 after buying an additional 421,931 shares in the last quarter. Ballast Asset Management LP grew its position in Bioceres Crop Solutions by 23.5% in the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company's stock valued at $2,620,000 after acquiring an additional 82,187 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock worth $708,000 after acquiring an additional 29,693 shares in the last quarter. Institutional investors and hedge funds own 17.68% of the company's stock.
About Bioceres Crop Solutions
(
Get Free Report)
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Featured Stories
Before you consider Bioceres Crop Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.
While Bioceres Crop Solutions currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
